Beyond Air (XAIR) Net Cash Flow (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,081.80% |
| Sep 30, 2025 | 228.87% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 100.80% |
| Dec 31, 2024 | -150.29% |
| Sep 30, 2024 | 582.99% |
| Jun 30, 2024 | -309.37% |
| Mar 31, 2024 | 145.31% |
| Dec 31, 2023 | 50.53% |
| Sep 30, 2023 | -198.11% |
| Jun 30, 2023 | -236.82% |
| Mar 31, 2023 | 186.41% |
| Dec 31, 2022 | 89.08% |
| Sep 30, 2022 | -430.90% |
| Jun 30, 2022 | -197.05% |
| Mar 31, 2022 | -104.54% |
| Dec 31, 2021 | 196.36% |
| Sep 30, 2021 | 337.90% |
| Jun 30, 2021 | -65.43% |
| Mar 31, 2021 | 4,090.70% |
| Dec 31, 2020 | 114.39% |
| Sep 30, 2020 | -105.13% |
| Jun 30, 2020 | -104.50% |
| Mar 31, 2020 | 5,277.68% |
| Dec 31, 2019 | -75.21% |
| Sep 30, 2019 | 341.66% |
| Jun 30, 2019 | -181.73% |
| Mar 31, 2019 | 424.42% |
| Dec 31, 2018 | 420.14% |
| Sep 30, 2018 | 84.78% |
| Jun 30, 2018 | 28.14% |
| Mar 31, 2018 | 92.09% |
| Dec 31, 2017 | -62.92% |
| Sep 30, 2017 | -86.58% |
| Jun 30, 2017 | -127.36% |
| Mar 31, 2017 | 54,974.64% |
| Dec 31, 2016 | -172.22% |
| Sep 30, 2016 | 164.29% |
| Jun 30, 2016 | 71.72% |